Table 2.
Obese children with DKA, with and without near-normoglycemic remission.
| Variable | Remission | No remission | P |
|---|---|---|---|
| N, % | 52 | 48 | |
| Age, years | 14.3 ± 2.2 | 13.7 ± 1.7 | 0.46 |
| Male gender, % | 64 | 80 | 0.64 |
| African American, % | 100 | 90 | 0.48 |
| Family history of DM, % | 89 | 100 | 0.47 |
| BMI, kg/m2 | 32.1 ± 6.0 | 30.7 ± 4.6 | 0.50 |
| Acanthosis Nigricans, % | 73 | 70 | >0.99 |
| Blood glucose, mmol/L | 40.5 ± 16 | 41.2 ± 29 | 0.60 |
| Bicarbonate, mequiv./L | 10.5 ± 5.7 | 12.4 ± 4.2 | 0.23 |
| A1C at presentation, % | 12.7 ± 1.5 | 11.9 ± 2.0 | 0.42 |
| Positive DM antibody, % | 36 | 40 | >0.99 |
| Metformin treatment, % | 73 | 10 | <0.01 |
| Time to remission (months) | 2.2 ± 2.3 | n/a | |
| A1C at 3–6 months follow up, % | 6.0 ± 0.9 | 7.4 ± 1.8 | 0.056 |
| A1C at 12 months follow up, % | 6.8 ± 1.4 | 12.3 ± 2.3 | <0.01 |
| Recurrence of DKA, % | 9 | 50 | 0.06 |
Data are presented as mean ± standard deviation.